- Home
- NAGE vs CCD Comparison
NAGE vs CCD Comparison
Compare NAGE & CCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAGE | CCD |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 507.6M | 579.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NAGE | CCD |
|---|---|---|
| Price | $6.57 | $21.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.33 | N/A |
| AVG Volume (30 Days) | ★ 807.8K | 96.1K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.61% |
| EPS Growth | ★ 1093.81 | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $124,709,000.00 | N/A |
| Revenue This Year | $30.37 | N/A |
| Revenue Next Year | $20.36 | N/A |
| P/E Ratio | $28.78 | ★ N/A |
| Revenue Growth | ★ 36.04 | N/A |
| 52 Week Low | $5.16 | $16.93 |
| 52 Week High | $14.69 | $24.68 |
Technical Indicators
Market Signals| Indicator | NAGE | CCD |
|---|---|---|
| Relative Strength Index (RSI) | 50.06 | 57.63 |
| Support Level | $6.18 | $20.80 |
| Resistance Level | $6.86 | $21.71 |
| Average True Range (ATR) | 0.27 | 0.34 |
| MACD | 0.04 | 0.05 |
| Stochastic Oscillator | 49.14 | 87.49 |
Price Performance
Historical ComparisonAbout NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About CCD Calamos Dynamic Convertible & Income Fund
Calamos Dynamic Convertible and Income Fund operates as a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It predominantly invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities.